Will J&J's US stent customers be left in lurch as Abbott ends supply deal?
This article was originally published in Clinica
Executive Summary
Abbott has decided to stop supplying Johnson & Johnson with its rapid exchange catheter, used in the US for implanting the latter's Cypher coronary sirolimus-eluting stent.